Manfred Mitterer
- Hematology top 5%
- Multiple Myeloma Research and Treatments 7
- Immunology and Allergy top 5%
- Oncology top 5%
- Viral-associated cancers and disorders 10
- COVID-19 and healthcare impacts 6
- Immunology top 10%
- Immune Cell Function and Interaction 6
- Genetics top 10%
-
- Lymphoma Diagnosis and Treatment 10
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 5
Manfred Mitterer
56 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Hematology 293
- Immunology and Allergy 136
- Oncology 526
- Immunology 279
- Genetics 110
Countries citing papers authored by Manfred Mitterer
This map shows the geographic impact of Manfred Mitterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Mitterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Mitterer more than expected).
Fields of papers citing papers by Manfred Mitterer
This network shows the impact of papers produced by Manfred Mitterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Mitterer. The network helps show where Manfred Mitterer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manfred Mitterer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 20 | |
| 3 | 2020 | 1 | |
| 4 | 2017 | 3 | |
| 5 | 2015 | 23 | |
| 6 | 2013 | 14 | |
| 7 | 2012 | 37 | |
| 8 | 2011 | 3 | |
| 9 | 2009 | 35 | |
| 10 | 2009 | 2 | |
| 11 | 2008 | 186 | |
| 12 | 2004 | 12 | |
| 13 | 2003 | 96 | |
| 14 | 2002 | 1 | |
| 15 | 2001 | 9 | |
| 16 | 1999 | 26 | |
| 17 | 1999 | 11 | |
| 18 | 1997 | 18 | |
| 19 | 1989 | 81 | |
| 20 | 1988 | 38 |
About Manfred Mitterer
Manfred Mitterer is a scholar working on Oncology, Hematology, Immunology, Pathology and Forensic Medicine and Internal Medicine, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Multiple Myeloma Research and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), COVID-19 and healthcare impacts (6 papers), Immune Cell Function and Interaction (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Hematology (293 citations), Immunology and Allergy (136 citations), Oncology (526 citations), Immunology (279 citations) and Genetics (110 citations). Manfred Mitterer has collaborated with scholars based in Italy, Austria and Germany. Frequent co-authors include Gilbert Spizzo, Dominic Fong, Patrizia Moser, Günther Gastl, Werner Vogetseder, Thomas F. Schulz, Johanna M. Gostner, R. Margreiter, Clara Larcher and Hartwig P. Huemer. Their work appears in journals such as British Journal of Haematology, Annals of Hematology, Annals of Oncology, International Journal of Cancer and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.